Murray Stewart

Executive Vice President R&D, NOVELION THERAPEUTICS INC.

Companies

Camp4 Therapeutics CorpBoard member Mar 19, 2025 to now¹
X4 Pharmaceuticals, IncBoard member Apr 2, 2019 to now²
X4 Pharmaceuticals, IncInterim Chief Medical Officer Aug 11, 2023 to Aug 11, 2023³
Amarin CorporationBoard member Jan 12, 2023 to Jan 12, 2023⁴
Rhythm (United states)Chief Medical Officer Oct 17, 2018 to Feb 16, 2021⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

X4 Pharmaceuticals, Inc XFOR7,883 shares⁶$20.2K at $2.56Jun 9, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 9, 2025Granted 1,500 shares of X4 Pharmaceuticals, Inc⁶
Jun 10, 2024Granted 45,000 shares of X4 Pharmaceuticals, Inc⁷
Aug 10, 2023Sold 130,056 shares at $1.06 of X4 Pharmaceuticals, Inc⁸
Aug 9, 2023Granted 269,893 shares of X4 Pharmaceuticals, Inc⁸
Jun 6, 2022Granted 6,667 shares of X4 Pharmaceuticals, Inc⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCamp4 Therapeutics Corp, Board member
2
SEC EDGARX4 Pharmaceuticals, Inc, Board member
3
SEC EDGARX4 Pharmaceuticals, Inc, Interim Chief Medical Officer
4
SEC EDGARAmarin Corporation, Board member
5
SEC EDGARRhythm (United states), Chief Medical Officer
6
SEC EDGARX4 Pharmaceuticals, Inc shares after the filing of Jun 9, 2025
7
SEC EDGARForm 4 filed Jun 11, 2024
8
SEC EDGARForm 4 filed Aug 11, 2023
9
SEC EDGARForm 4 filed Jun 27, 2022